Aerie Pharmaceuticals reported $21.41M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Aerie Pharmaceuticals AERI:US $ 21.41M 0.41M
Amarin AMRN:US $ 111.83M 10.51M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Coherus Biosciences CHRS:US $ 61.22M 9.72M
Endo International Ordinary Shares ENDP:US $ 474.91M 74.51M
Flexion Therapeutics FLXN:US $ 17.6M 5.6M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Horizon Pharma HZNP:US $ 785.35M 153.8M
Insmed INSM:US $ 36.57M 2.04M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Merk MRK:US $ 10098M 1738M
Novartis NOVN:VX 9.52B 21M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Revance Therapeutics RVNC:US $ 13.86M 481K
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M
Valeant Pharmaceuticals VRX:CN $ 1529M 41M
Zoetis ZTS:US $ 1408M 24M
Zogenix ZGNX:US $ 21.32M 3.75M